Devopharma ApS — Credit Rating and Financial Key Figures
CVR number: 38968254
Strandvejen 301, 2920 Charlottenlund
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -3.13 | -3.13 | -3.13 | -3.13 | -3.13 |
| EBIT | -3.13 | -3.13 | -3.13 | -3.13 | -3.13 |
| Pre-tax profit | -3.13 | -3.13 | -3.13 | -3.13 | -3.13 |
| Net earnings | -3.13 | -3.13 | -3.13 | -3.13 | -3.13 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Investments total | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Short term receivables total | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Balance sheet total (assets) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -3.13 | -6.25 | -9.38 | -12.50 | -15.63 |
| Profit of the financial year | -3.13 | -3.13 | -3.13 | -3.13 | -3.13 |
| Shareholders equity total | 43.75 | 40.63 | 37.50 | 34.38 | 31.25 |
| Non-current liabilities total | |||||
| Current owed to group member | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Other non-interest bearing current liabilities | 6.25 | 9.38 | 12.50 | 15.63 | 18.75 |
| Current liabilities total | 56.25 | 59.38 | 62.50 | 65.63 | 68.75 |
| Balance sheet total (liabilities) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.